Even Martin Shkreli’s old lawyer wanted to get away from him, and a judge finally granted his wish Wednesday.

Shkreli’s former lawyer and co-defendant, Evan Greebel, had asked to have their cases separated in February, calling the “Pharma Bro” a serial liar “guilty of committing fraud.”

The papers alleged that Shkreli, 33, used his company lawyers as oblivious “pawns” in his schemes, in which he conspired to drain his company, Retrophin, of millions to pay off investors Shkreli was accused of defrauding.

A Brooklyn federal judge agreed to split the pair’s cases.

“One defendant, Shkreli, intends to present a defense that no crime was committed because he lacked the requisite intent, while his co-defendant, Greebel, intends to present evidence and argue that Shkreli is guilty as charged, and that Greebel is but another victim of Shkreli’s lies and deceitfulness — a pawn in “fraudulent schemes unbeknownst to [him],” Brooklyn federal court Judge Kiyo A. Matsumoto wrote in her decision.

“These defenses amount to more than simple finger-pointing by two defendants. Rather, the defense strategy of Shkreli’s co-defendant presents a realistic scenario that Shkreli will be prosecuted, not only by the government, but also by Greebel, his co-defendants” she said.

see also

Federal prosecutors said Tuesday they are mulling additional securities fraud...

“Nothing has been able to stop — and nothing will be able to stop — Mr. Shkreli from trying to turn this trial into a circus as part of a deliberate strategy to obtain jury nullification rather than have the jury focus on and carefully consider the evidence,” Greebel’s original severance motion read.

Shkreli, 33, was labeled the “Most Hated Man in America” for jacking up the price of a potentially life-saving drug by nearly 5,000 percent before he was busted on securities fraud charges for allegedly running an $11 million Ponzi scheme.

Greebel had been charged alongside Shkreli in the 11-count indictment.

Both men have pleaded “not guilty” to the charges.

The disgraced former pharmaceutical exec and hedge-fund manager remains out on $5 million bail.